Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by ViatrisGlobeNewsWire • 11/07/22
Viatris Announces Two Acquisitions to Create What it Expects to be a Leading Ophthalmology Franchise; Plans to Provide Strategic Update on its February 2022 Investor EventPRNewsWire • 11/07/22
Viatris to Report Financial Results for the Third Quarter 2022 and Provide an Update on its February 28 Investor Event on November 7, 2022PRNewsWire • 10/24/22
Viatris Named to Forbes' Annual List of the World's Best Employers for the Second Year in a RowPRNewsWire • 10/11/22
Viatris Inc.'s (VTRS) BofA Global Research Global Healthcare Conference TranscriptSeeking Alpha • 09/15/22